US · COCHW
Envoy Medical, Inc.
- Sector
- Healthcare · Medical - Devices
- Headquarters
- White Bear Lake, MN 55110
- Website
- envoymedical.com
Price · as of 2024-12-31
$0.07
Market cap 1.01M
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | — | — |
| Intrinsic Value(DCF) | — | — |
| Graham-Dodd Method(GD) | — | — |
| Graham Formula(GF) | $21.49 | +30,775% |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2010 | |||||
| 2011 | |||||
| 2012 | |||||
| 2013 | |||||
| 2014 | |||||
| 2015 | |||||
| 2016 | |||||
| 2017 | |||||
| 2018 | |||||
| 2019 | |||||
| 2020 | |||||
| 2021 | |||||
| 2022 | $0.00 | $22.65 | |||
| 2023 | $0.00 | $0.00 | |||
| 2024 | $0.00 | $21.49 |
AI valuation
Our deep-learning model estimates Envoy Medical, Inc.'s (COCHW) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- —
- Current price
- $0.07
- AI upside
- —
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
—
— upside
Graham-Dodd
—
— upside
Graham Formula
$21.49
+30,775% upside
Peer comparison
Same-industry comparables, ranked by market cap.
| Basic Info | Model Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| COCHW | Envoy Medical, Inc. | $0.07 | 1.01M | — | — | — | +30,775% | — | — | — | — | — | — | -229.78% | -8558.22% | -9242.22% | 217.79% | 381.46% | -226.68% | -1.04 | -23.60 | 1.24 | 0.84 | -0.72 | -4134.00% | -2880.00% | 977.00% | — | -2.38 | 374.98% | — | -10.90% | — | — | — | — | — |
| CCM | Concord Medical Services … | $3.64 | 530.04K | +8,914% | -53% | — | +156,680% | -0.01 | 0.00 | 0.01 | -10.37 | -0.19 | 0.00 | -20.62% | -138.60% | -80.28% | 29.62% | -42.92% | -10.20% | -1.72 | -2.75 | 0.46 | 0.19 | -10.75 | 355.00% | -2855.00% | 10618.00% | -18065.77% | -0.19 | -66.96% | 0.00% | 0.00% | 0.00% | -6.74 | -4.43 | 9.34 | -1.32 |
| CDT | CDT Equity Inc. | $0.69 | 936.98K | — | +2,355% | +4,622% | — | 0.11 | 0.02 | 0.01 | 3.22 | — | -0.15 | 37.98% | 11.63% | 8.75% | 37.77% | 28.00% | 13.64% | 1.09 | -6.81 | 1.93 | 1.22 | 3.14 | -12879.00% | — | -234691.00% | 845.61% | 0.51 | 19.40% | 30.80% | 3.40% | 30.80% | 3.22 | 4.65 | 0.37 | 1.88 |
| NIVF | NewGenIvf Group Limited | $0.83 | 20.24K | +316,275% | +44,719% | — | — | -223.33 | -100.97 | 19.49 | 4469.74 | — | -100.97 | 33.63% | -21.35% | -9.66% | -35.29% | -20.66% | -11.76% | -2.89 | -1.49 | 1.17 | 1.04 | 106.02 | -27938.00% | 578.00% | 35301.00% | -7.86% | -3.04 | -300.37% | 0.00% | 0.00% | 0.00% | -93.49 | -13.04 | 19.96 | 12.77 |
| WORX | SCWorx Corp. | $0.33 | 1.37M | +13,567% | +79% | — | +2,775% | -1.19 | 0.30 | 0.45 | 5.66 | — | -1.00 | 24.95% | -42.13% | -38.01% | -27.24% | -30.41% | -18.00% | 0.01 | -12.09 | 0.27 | 0.26 | -0.26 | -7979.00% | -2143.00% | 3450.00% | -80.45% | -0.59 | -26.18% | 0.00% | 0.00% | 4.34% | -1.02 | -1.19 | 0.43 | -6.83 |
About Envoy Medical, Inc.
Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.
- CEO
- Brent T. Lucas
- Employees
- 42
- Beta
- 2.09
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as (— ÷ $0.07) − 1 = — (DCF, example).